Clinical Trials

45 enrolled

Gynecologic

Ovarian Neoplasms

NCT06294054 2024-03-06

SELECT

707 enrolled

Genitourinary

Urinary Bladder Neoplasms, Genomic Instability

NCT05980689 2024-02-07

Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer

33 enrolled

Locally Advanced Rectal Cancer

NCT06223763 2024-01-25

SUROVA

5,000 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT06003673 2023-10-24

A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC

Phase 4 Unknown

20 enrolled

Carcinoma, Hepatocellular

NCT05912062 2023-09-29

BiOnHER

80 enrolled

Breast Neoplasms, Neoplasms

NCT04135690 2023-08-15

HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial

60 enrolled

Carcinoma, Hepatocellular

NCT01628211 2023-03-24

HIPEC

140 enrolled

Colorectal Neoplasms

NCT05323890 2023-03-14

Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma.

15 enrolled

Advanced Esophageal Squamous Cell Cancer

NCT04929067 2023-02-17

Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma: a Phase II Clinical Trial

39 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05642104 2022-12-08

The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy

175 enrolled

Breast Neoplasms

NCT04197076 2022-07-29

Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05479409 2022-07-29

Neoadjuvant Radiation in Locally Advanced Breast Cancer

Breast Neoplasms

NCT05476965 2022-07-27

iCSDeR

20 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05468177 2022-07-21

CIFOXRC

66 enrolled

Colonic Neoplasms

NCT04755907 2022-07-19

3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases

120 enrolled

Colorectal Neoplasms

NCT05351762 2022-07-05

Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC

55 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05424432 2022-06-27

SCALE-2

63 enrolled

Esophageal Neoplasms

NCT03623737 2022-06-07

Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC

Phase 2/3 Unknown

248 enrolled

Esophageal Squamous Cell Carcinoma

NCT05399394 2022-06-01

FOLRT

Pancreatic Neoplasms

NCT05371197 2022-05-12

Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer

26 enrolled

Turcot syndrome, Colorectal Neoplasms

NCT05340231 2022-04-22

An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)

Colorectal Neoplasms

NCT05341479 2022-04-22

An Observational Study of Clinical Treatments for Patients With Oropharyngeal Carcinoma

200 enrolled

Oropharyngeal Neoplasms

NCT03366415 2022-03-04

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

Phase 3 Unknown

420 enrolled

Nasopharyngeal Carcinoma

NCT05113459 2021-11-09

Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018）

40 enrolled

Stomach Neoplasms

NCT02305186 2021-08-13

UVA-PC-PD101

Phase 1/2 Unknown

68 enrolled

Pancreatic Neoplasms

NCT04968002 2021-07-20

Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy

Phase 2/3 Unknown

40 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04966975 2021-07-19

Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy

60 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02277938 2021-03-17

Acetylamantadine Excretion by Cancer Patients

120 enrolled

Tumor-Agnostic

Neoplasms

NCT04798976 2021-03-16

Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer

3,000 enrolled

Breast Cancer-specific Survival

NCT04170179 2021-02-23

Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis

25 enrolled

Carcinoma, Hepatocellular

NCT02972541 2021-02-08

NACSOC

248 enrolled

Bites and Stings, Colorectal Neoplasms

NCT03504449 2021-02-08

SCRM-01

350 enrolled

Circumferential Resection Margin

NCT04654195 2020-12-04

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

Breast Cancer Patients

NCT04606108 2020-10-28

Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma

62 enrolled

NCT04581967 2020-10-09

Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients

Breast Cancer Patients

NCT04523402 2020-08-21

Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis

Cholangiocarcinoma

NCT04506281 2020-08-10

PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

128 enrolled

Cholangiocarcinoma

NCT04411524 2020-06-02

The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

NCT04411537 2020-06-02

The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

NCT04408859 2020-05-29

Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy

290 enrolled

QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy

NCT04360655 2020-04-24

Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLC

Effect Increased

NCT04319874 2020-03-30

Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma

80 enrolled

Osteosarcoma

NCT04316091 2020-03-20

A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma

Phase 1 Unknown

60 enrolled

Osteosarcoma

NCT04294511 2020-03-04

Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma

75 enrolled

Osteosarcoma

NCT02251353 2020-02-21

IMET

300 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT04264468 2020-02-11

CMTNCMB

150 enrolled

Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer

NCT04257786 2020-02-06

ovarian cancer

80 enrolled

Advanced Cancer

NCT04245618 2020-01-30

Neoadjuvant Chemotherapy in Non Muscle Invasive T1b Bladder Cancer